On October 31, the University of Waterloo launched the Graham Seed Fund program – a funding opportunity designed to broadly encourage innovative health care solutions for challenges of today and tomorrow from the “patient perspective” and a pipeline for research and innovation at the intersection of health, technology and society.
The Graham Seed Fund is now accepting applications for new projects that will work towards the University’s strategic priority of creating a globally recognized hub for innovative and transformative health technologies.
The Centre for Bioengineering and Biotechnology (CBB) hosted a virtual information session which featured Dr. Kathleen Marsman from Borden Ladner Gervais LLP, the current Chair of the CIHR Commercialization (CMZ) Peer Review Committee (PRC) of the Project Grant Program.
The Centre for Bioengineering and Biotechnology (CBB) hosted a virtual information session which featured Professor Douglas Hamilton, past Chair, and Milica Radisic, Scientific Officer of the CIHR Biomedical Engineering Peer Review Committee (BME PRC).